Max Robotics — Global Service Robot Directory + US Certification

About

Paul Rouse is a pioneering researcher at the intersection of robotics and chronic disease management, with a primary focus on leveraging socially assistive robots to improve outcomes for patients with Chronic Obstructive Pulmonary Disease (COPD). His major contributions include conducting the first pilot randomized controlled trial demonstrating that robots can be effectively deployed in home settings to support COPD patients, addressing critical gaps in medication adherence and rehabilitation access. This landmark 2018 study has garnered 128 citations, underscoring its influence in the field. Rouse has also advanced the economic case for healthcare robotics, notably through a 2015 study on the cost-effectiveness of robots measuring vital signs in rural medical practices—a work that, while smaller in citation count (27), provides foundational evidence for reducing healthcare costs in underserved areas. His research uniquely bridges clinical efficacy and economic viability, offering practical pathways for integrating robots into routine care. By proving that robots can both enhance patient self-management and lower system expenses, Rouse has established himself as a key voice in the movement toward scalable, technology-driven home healthcare solutions.